Head Of Molecular Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Roche receives FDA authorisation for testing of asymptomatic people with the cobas SARS-CoV-2 Test to help control the spread of COVID-19

The high-throughput, highly sensitive cobas SARS-CoV-2 Test under FDA Emergency Use Authorisation can now be used to test individual or pooled samples from people without symptoms or other reasons to suspect COVID-19

Accurate, reliable and early detection of SARS-CoV-2 in potentially exposed individuals can help limit the spread of disease
PLEASANTON, Calif., May 18, 2021 /PRNewswire/ Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its
cobas SARS-CoV-2 Test for use on the widely available, high-throughput
cobas 6800/8800 Systems has received Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA) for testing individuals without symptoms or reasons to suspect COVID-19. This authorisation supports the guidance update from the U.S. Centers for Disease Control and Prevention ....

United States , Mike Weist , Elizabeth Baxter , Cindy Perettie , Centers For Disease , Us Centers For Disease , Head Of Molecular Lab , World Health Organization , Drug Administration , Roche Diagnostics Solutions , Clinical Laboratory Improvement Amendments , Roche Group , Pharmaceuticals Industry , Drug Administration Emergency Use Authorization , Use Authorisation , Emergency Use Authorisation , Disease Control , Molecular Lab , Roche Diagnostics , Middle East Respiratory Syndrome , Severe Acute Respiratory Syndrome , Emergency Use Authorization , Emergency Use , World Health Organization Model Lists , Essential Medicines , Dow Jones Sustainability Indices ,